Crestwood Midstream Stock To Go Ex-dividend Tomorrow (CMLP)

NEW YORK ( TheStreet) -- The ex-dividend date for Crestwood Midstream Partners (NYSE: CMLP) is tomorrow, January 27, 2012. Owners of shares as of market close today will be eligible for a dividend of 49 cents per share. At a price of $30.18 as of 9:30 a.m. ET, the dividend yield is 6.5%.

The average volume for Crestwood Midstream has been 108,600 shares per day over the past 30 days. Crestwood Midstream has a market cap of $1 billion and is part of the basic materials sector and energy industry. Shares are down 4.3% year to date as of the close of trading on Wednesday.

Crestwood Midstream Partners LP engages in gathering, compressing, treating, processing, and transporting natural gas primarily on the Barnett Shale formation of the Fort Worth Basin in north Texas. The company has a P/E ratio of 34.1, equal to the average energy industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Crestwood Midstream as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Crestwood Midstream Ratings Report.

See our dividend calendar or top-yielding stocks list.

null

More from Markets

What Angela Merkel's Uncertain Political Future Means for Greece's Debt Woes

What Angela Merkel's Uncertain Political Future Means for Greece's Debt Woes

Dow Tumbles, Stocks Slide on Renewed Trade War Concerns

Dow Tumbles, Stocks Slide on Renewed Trade War Concerns

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Goldman Is Bullish on Oil, Sees Demand Outweighing Inventory Concern

Goldman Is Bullish on Oil, Sees Demand Outweighing Inventory Concern

Jim Cramer: Centene Is in All the Big Medicare Markets

Jim Cramer: Centene Is in All the Big Medicare Markets